Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
Go back to Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results| (NASDAQ: FULC) | Delayed: 3.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.70 | 52 Week High | $ | |||
| Open | $3.73 | 52 Week Low | $ | |||
| Day High | $3.73 | P/E | N/A | |||
| Day Low | $3.67 | EPS | $ | |||
| Volume | 1,582,528 | |||||

